Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELENIUM SULFIDE: 545 Adverse Event Reports & Safety Profile

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra
545
Total FAERS Reports
0
Deaths Reported
17
Hospitalizations
545
As Primary/Secondary Suspect
2
Life-Threatening
4
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
FAMILY DOLLAR SERVICES INC
Manufacturer
Discontinued
Status
Yes
Generic Available

Route: TOPICAL · Manufacturer: FAMILY DOLLAR SERVICES INC · FDA Application: 007936 · HUMAN OTC DRUG · FDA Label: Available

First Report: 2012 · Latest Report: 20250101

What Are the Most Common SELENIUM SULFIDE Side Effects?

#1 Most Reported
Drug ineffective
126 reports (23.1%)
#2 Most Reported
Hair colour changes
60 reports (11.0%)
#3 Most Reported
No adverse event
52 reports (9.5%)

All SELENIUM SULFIDE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 126 23.1% 0 0
Hair colour changes 60 11.0% 0 0
No adverse event 52 9.5% 0 0
Pruritus 51 9.4% 0 0
Hair texture abnormal 40 7.3% 0 0
Alopecia 38 7.0% 0 0
Product odour abnormal 31 5.7% 0 0
Condition aggravated 26 4.8% 0 0
Dry skin 22 4.0% 0 0
Therapeutic response decreased 21 3.9% 0 0
Skin exfoliation 18 3.3% 0 1
Skin irritation 17 3.1% 0 0
Dandruff 15 2.8% 0 0
Product colour issue 15 2.8% 0 0
Seborrhoea 15 2.8% 0 0
Erythema 13 2.4% 0 0
Pain 13 2.4% 0 2
Rash 13 2.4% 0 3
Skin burning sensation 13 2.4% 0 1
Product use in unapproved indication 12 2.2% 0 0

Who Reports SELENIUM SULFIDE Side Effects? Age & Gender Data

Gender: 50.6% female, 49.4% male. Average age: 52.7 years. Most reports from: US. View detailed demographics →

Is SELENIUM SULFIDE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 3 0 0
2014 5 0 0
2015 4 0 0
2016 8 0 0
2017 10 0 4
2018 15 0 5
2019 4 0 0
2020 11 0 0
2021 7 0 0
2022 8 0 2
2023 1 0 0
2024 8 0 0
2025 1 0 1

View full timeline →

What Is SELENIUM SULFIDE Used For?

IndicationReports
Product used for unknown indication 90
Dandruff 78
Pruritus 46
Dry skin 28
Seborrhoeic dermatitis 24
Tinea versicolour 11
Psoriasis 8
Fungal infection 5

SELENIUM SULFIDE vs Alternatives: Which Is Safer?

SELENIUM SULFIDE vs SELEXIPAG SELENIUM SULFIDE vs SELINEXOR SELENIUM SULFIDE vs SELPERCATINIB SELENIUM SULFIDE vs SELUMETINIB SELENIUM SULFIDE vs SEMAGLUTIDE SELENIUM SULFIDE vs SEMUSTINE SELENIUM SULFIDE vs SENNA LEAF SELENIUM SULFIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B SELENIUM SULFIDE vs SENNOSIDES SELENIUM SULFIDE vs SENNOSIDES A AND B

Official FDA Label for SELENIUM SULFIDE

Official prescribing information from the FDA-approved drug label.

Drug Description

DESCRIPTION: Each mL of Selenium Sulfide 2.25% Shampoo contains 22.5mg selenium sulfide, ammonium lauryl sulfate, caprylic/capric triglyceride, chromium oxide green, citric acid, cocamidopropyl betaine, D&C yellow No. 8, diazolidinyl urea, distearyl phthalic acid amide, edetate disodium, FD&C red No. 40, fragrance, hydroxypropyl methylcellulose, magnesium aluminum silicate, methylparaben, panthenol, PPG-2 hydroxyethyl coco/isostearamide, propylene glycol, propylparaben, purified water, sodium citrate, titanium dioxide, tocopheryl acetate, urea and zinc pyrithione.

FDA Approved Uses (Indications)

INDICATIONS: This product is a liquid antiseborrheic, antifungal preparation useful for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. Urea hydrates and is useful for conditions such as dry scalp.

Dosage & Administration

DOSAGE AND ADMINISTRATION: SHAKE WELL BEFORE USING For seborrheic dermatitis and dandruff: Wet skin and apply to areas to be cleansed. Massage gently into the skin working into a full lather. Rinse thoroughly and pat dry. Generally two applications each week for two weeks will control symptoms. Subsequently, shampoo may be used less frequently, or as directed by a physician. It should not be applied more frequently than necessary to maintain control. For tinea versicolor : Wet skin and apply to areas to be cleansed. Massage gently into the skin working into a full lather. Allow product to remain on skin for ten minutes, then rinse thoroughly and pat dry. Repeat procedure once a day for seven days or as directed by a physician.

Contraindications

CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

Known Adverse Reactions

ADVERSE REACTIONS In decreasing order of severity: skin irritation; occasional reports of increase in normal hair loss; discoloration of hair (can be avoided or minimized by thorough rinsing of hair after treatment). As with other shampoos, oiliness or dryness of hair and scalp may occur. To report a serious adverse event, please contact Westminster Pharmaceuticals at 1-844-221-7294 or call FDA at 1-800-FDA-1088 or fda.gov/medwatch.

Warnings

Warnings For external use only. Ask a doctor before use you have seborrheic dermatitis in areas other than the scalp. When using this Product Avoid contact with eyes. If contact occurs, rinse thoroughly with water. For use on color treated or permed hair, rinse thoroughly. Stop use and ask a doctor if Condition worsens or does not improve after regular use of this product as directed. Keep out of reach of children In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Precautions

PRECAUTIONS General - Should not be used when acute inflammation or exudation is present as increased absorption may occur. Information for Patients - Application to skin or scalp may produce skin irritation or sensitization. If sensitivity reactions occur, use should be discontinued. May be irritating to mucous membranes of the eyes and contact with this area should be avoided. When applied to the body for treatment of tinea versicolor, Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) may produce skin irritation especially in the genital area and where skin folds occur. These areas should be thoroughly rinsed after application. Carcinogenesis - Studies in mice using dermal application of 25% and 50% solutions of 2.5% selenium sulfide topical suspension, over an 88 week period, indicated no carcinogenic effects. Pregnancy - WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE IS CLASSIFIED AS PREGNANCY CATEGORY "C". Animal reproduction studies have not been conducted with Selenium Sulfide Topical Suspension USP, 2.5% (Lotion). It is also not known whether Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances Selenium Sulfide Topical Suspension USP, 2.5% (Lotion) should not be used for the treatment of tinea versicolor in pregnant women.

Pediatric

Use - Safety and effectiveness in infants have not been established.

Active Ingredient

Active ingredient Selenium Sulfide, micronized 0,6 %

Inactive Ingredients

WATER SODIUM LAURETH SULFATE COCAMIDOPROPYL BETAINE DIMETHICONOL SODIUM CHLORIDE DIAMINOPYRIMIDINE OXIDE SODIUM LAURYL SULFATE SODIUM SALICYLATE GLYCERIN PHENOXYETHANOL GLYCOL DISTEARATE SODIUM BENZOATE FRAGRANCE FRESH CITRUS FLORAL ORC1501495 SODIUM METHYL COCOYL TAURATE HYDROGENATED CASTOR OIL GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE ZINC PCA CITRIC ACID LAURETH-3 DICHLOROBENZYL ALCOHOL SULFUR GLYCOL STEARATE LAURIC ACID ETHYLHEXYLGLYCERIN PLATYCLADUS ORIENTALIS LEAF AVENA SATIVA (OAT) KERNEL OIL CENTELLA ASIATICA LIMOSILACTOBACILLUS FERMENTUM CAMELLIA SINENSIS LEAF PORTULACA OLERACEA WHOLE SOPHORA FLAVESCENS WHOLE MACADAMIA INTEGRIFOLIA SEED OIL ZINGIBER OFFICINALE (GINGER) ROOT OIL ROSMARINUS OFFICINALIS (ROSEMARY) LEAF OIL PRINSEPIA UTILIS SEED CERAMIDE NP RHINACANTHUS NASUTUS WHOLE